Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic value of a composite physiologic index developed by adding bronchial and hyperlucent volumes quantified via artificial intelligence technology.
Uyama M, Handa T, Uozumi R, Hashimoto S, Taguchi Y, Ikezoe K, Tanizawa K, Tanabe N, Oguma T, Matsunashi A, Niwamoto T, Shima H, Mori R, Maetani T, Shiraishi Y, Nobashi TW, Sakamoto R, Kubo T, Yoshizawa A, Terada K, Nakamoto Y, Hirai T. Uyama M, et al. Among authors: nakamoto y. Respir Res. 2024 Dec 24;25(1):442. doi: 10.1186/s12931-024-03075-8. Respir Res. 2024. PMID: 39719582 Free PMC article.
Neural substrates underlying distinct dual cognitive syndromes in Parkinson's disease.
Yoshimura K, Shima A, Kambe D, Furukawa K, Nishida A, Wada I, Sakato Y, Sakamaki-Tsukita H, Terada Y, Yamakado H, Taruno Y, Nakanishi E, Sawamura M, Fujimoto K, Fushimi Y, Okada T, Nakamoto Y, Hanakawa T, Takahashi R, Sawamoto N. Yoshimura K, et al. Among authors: nakamoto y. Eur J Neurol. 2025 Jan;32(1):e70022. doi: 10.1111/ene.70022. Eur J Neurol. 2025. PMID: 39716907 Free PMC article.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
906 results